title: Mapping of murine IgE epitopes involved in IgE-Fc epsilon receptor interactions.
abstract: The generation of anti-IgE monoclonal antibodies has permitted the identification of various serological epitopes on the IgE molecule. The relationship of the sites on IgE recognized by such antibodies to the Fc epsilon receptor (Fc epsilon R) interaction site has been determined using cross-inhibition studies. However, interpretation of this type of experiment is limited by problems of steric hindrance. Thus, to accomplish precise mapping on the IgE molecule of the Fc epsilon R interaction site and the binding sites of various anti-IgE mAb, we employed site-directed mutagenesis of the IgE heavy chain gene. To this end we have constructed and expressed a recombinant murine constant epsilon heavy chain (C epsilon) gene bearing a (4-hydroxy-3-nitrophenyl)acetic acid (NP)-binding VH region. Several site-specific mutants in the C epsilon 3 and C epsilon 4 domains of this recombinant C epsilon gene were prepared and expressed by transfection into the light chain-producing J558L myeloma cell line. The resulting IgE antibodies were tested for binding to mast cells and to various anti-IgE mAb. The mutants produced include a proline to histidine point mutant at amino acid residue 404 in the C epsilon 3 domain, a mutant with a truncated C epsilon 4 domain, a mutant with a 45 amino acid deletion in the carboxy end of C epsilon 3, and a chimeric human C epsilon in which the human C epsilon 3 was replaced by the homologous mouse C epsilon 3 domain. These mutants have permitted the localization, to the C epsilon 3 domain, of the epitopes recognized by the 84.1C and 95.3 anti-IgE mAb. The 84.1C mAb recognizes a site on IgE which is identical or very close to the Fc epsilon R binding site, and 95.3 recognizes a site on IgE which is related, but not identical to the Fc epsilon R binding site. The antigenic determinant recognized by the 51.3 mAb, which is inefficient at blocking the IgE-Fc epsilon R interaction, has been mapped to the C epsilon 4 domain. When tested for binding to the Fc epsilon R on RBL-2H3 cells, the point mutant bound to the Fc epsilon R with twofold reduced affinity, while the C epsilon 3 deletion mutant and the mutant truncated in C epsilon 4 lost all receptor binding activity.(ABSTRACT TRUNCATED AT 400 WORDS)
authors: Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
authors: S
authors: S
authors: Schwarzbaum
authors: A
authors: A
authors: Nissim
authors: I
authors: I
authors: Alkalay
authors: M C
authors: MC
authors: Ghozi
authors: D G
authors: DG
authors: Schindler
authors: Y
authors: Y
authors: Bergman
authors: Z
authors: Z
authors: Eshhar
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology* / Q000378:metabolism; D001681:Biological Assay; D003001:Cloning, Molecular; D004252:DNA Mutational Analysis; D000939:Epitopes; D007073:Immunoglobulin E / Q000378:metabolism*; D008407:Mast Cells / Q000276:immunology; D051379:Mice; D008969:Molecular Sequence Data; D009592:Nitrohydroxyiodophenylacetate / Q000276:immunology; D011485:Protein Binding; D011961:Receptors, Fc / Q000276:immunology* / Q000378:metabolism; D017455:Receptors, IgE; D013329:Structure-Activity Relationship
chemical_list: D000911:Antibodies, Monoclonal; D000944:Antigens, Differentiation, B-Lymphocyte; D000939:Epitopes; D011961:Receptors, Fc; D017455:Receptors, IgE; D009592:Nitrohydroxyiodophenylacetate; D007073:Immunoglobulin E